(Q47123984)
Statements
1 reference
OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial (English)
1 reference
I Poizot-Martin
1 reference
D Salmon-Céron
1 reference
C Durier
1 reference
C Desaint
1 reference
Cuzin
1 reference
M Surenaud
1 reference
Y Hénin
1 reference
J Lelièvre
1 reference
B Bonnet
1 reference
G Pialoux
1 reference
N Ben Hamouda
1 reference
A Jackson
1 reference
C Flys
1 reference
C Guérin
1 reference
J Aboulker
1 reference
J Choppin
1 reference
O Launay
1 reference
22 October 2009
1 reference
1 reference
6
1 reference
Suppl 3
1 reference
O25-O25
1 reference
1 October 2009
1 reference